Mobile health technology (mDiab) for the prevention of type 2 diabetes: protocol for a randomized controlled trial by Muralidharan, Shruti et al.
 DRO  
Deakin Research Online, 
Deakin University’s Research Repository  Deakin University CRICOS Provider Code: 00113B 
Mobile health technology (mDiab) for the prevention of type 2 diabetes: protocol 
for a randomized controlled trial 
Citation:  
Muralidharan, Shruti, Mohan, Viswanathan, Anjana, Ranjit Mohan, Jena, Sidhant, Tandon, Nikhil, 
Allender, Steven and Ranjani, Harish 2017, Mobile health technology (mDiab) for the prevention 
of type 2 diabetes: protocol for a randomized controlled trial, JMIR research protocols, vol. 6, no. 
12, Article number e242, pp. 1-12. 
DOI: http://www.dx.doi.org/10.2196/resprot.8644 
 
 
 
 
© 2017, The Authors 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
Downloaded from DRO:  
http://hdl.handle.net/10536/DRO/DU:30109240 
Protocol
Mobile Health Technology (mDiab) for the Prevention of Type 2
Diabetes: Protocol for a Randomized Controlled Trial
Shruti Muralidharan1, MSc; Viswanathan Mohan2, MD, PhD, DSc, FRCP; Ranjit Mohan Anjana2, MD, PhD; Sidhant
Jena3, MBA, MS; Nikhil Tandon4, MBBS, MD, PhD; Steven Allender1, Hon MFOM (UK), PhD; Harish Ranjani2,
CDE, PhD
1Global Obesity Centre, World Health Organization Collaborating Centre for Obesity Prevention, Deakin University, Geelong, Australia
2Translational Research Department, Madras Diabetes Research Foundation, Dr. Mohan's Diabetes Specialities Centre, Chennai, India
3Janacare Solutions Private Limited, Bengaluru, India
4Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India
Corresponding Author:
Harish Ranjani, CDE, PhD
Translational Research Department
Madras Diabetes Research Foundation
Dr. Mohan's Diabetes Specialities Centre
No 4, Conron Smith Road,
Gopalapuram
Chennai, 600086
India
Phone: 91 4443968888
Fax: 91 4428350935
Email: ranjani@mdrf.in
Abstract
Background: The prevalence of type 2 diabetes is increasing in epidemic proportions in low- and middle-income countries.
There is an urgent need for novel methods to tackle the increasing incidence of diabetes. The ubiquity of mobile phone use and
access to Internet makes mobile health (mHealth) technology a viable tool to prevent and manage diabetes.
Objective: The objective of this randomized controlled trial is to implement and evaluate the feasibility, cost-effectiveness, and
sustainability of a reality television–based lifestyle intervention program. This intervention program is delivered via a mobile
phone app (mDiab) to approximately 1500 Android smartphone users who are adults at a high risk for type 2 diabetes from three
cities in India, namely, Chennai, Bengaluru, and New Delhi.
Methods: The mDiab intervention would be delivered via a mobile phone app along with weekly coach calls for 12 weeks.
Each participant will go through a maintenance phase of 6 to 8 months post intervention. Overall, there would be 3 testing time
points in the study: baseline, post intervention, and the end of follow-up. The app will enable individuals to track their weight,
physical activity, and diet alongside weekly video lessons on type 2 diabetes prevention.
Results: The study outcomes are weight loss (primary measure of effectiveness); improvement in cardiometabolic risk factors
(ie, waist circumference, blood pressure, glucose, insulin, and lipids); and improvement in physical activity, quality of life, and
dietary habits. Sustainability will be assessed through focus group discussions.
Conclusions: If successful, mDiab can be used as a model for translational and implementation research in the use of mHealth
technology for diabetes prevention and may be further expanded for the prevention of other noncommunicable diseases such as
hypertension and cardiovascular diseases.
Trial Registration: Clinical Trials Registry of India CTRI/2015/07/006011 http://ctri.nic.in/Clinicaltrials/pdf_generate.php?
trialid=11841 (Archived by WebCite at http://www.webcitation.org/6urCS5kMB)
(JMIR Res Protoc 2017;6(12):e242)   doi:10.2196/resprot.8644
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Introduction
The International Diabetes Federation estimates the global
prevalence of type 2 diabetes mellitus (T2DM) to rise to 642
million by 2040 from the current number of 415 million [1].
Three-fourths of this population lives in the low- and
middle-income countries (LMICs) such as India [1-3]. Studies
in different populations have shown that a large part of T2DM
is attributed to factors such as obesity (both generalized and
abdominal), sedentary lifestyle, and poor diet [4-7]. Anjana et
al [8] assessed the population attributable risks in an urban
Indian population and reported that by modifying just two
factors, namely, diet and physical activity, up to 50% of new
onset T2DM can be prevented.
Several randomized controlled trials (RCTs) carried out on
primary prevention of T2DM have shown that lifestyle
modification and metformin therapy can reduce the incidence
of T2DM in people who are in the prediabetes stage, that is,
those having impaired glucose tolerance (IGT) or impaired
fasting glucose (IFG), or both [9-16]. However, most of these
trials were conducted face to face. This involves a lot of man
power, cost, and time. The question arises whether similar results
can be obtained using modern technology without the need for
face-to-face interaction.
The World Health Organization (WHO) considers mobile health
(mHealth) as a component of electronic health (eHealth). The
definition of eHealth according to the WHO is “the use of
information and communication technologies for health,” and
mHealth is defined as “medical and public health practice
supported by mobile devices, such as mobile phones, patient
monitoring devices, personal digital assistants (PDAs), and
other wireless devices” [17].
It is of interest to note that India stands second worldwide both
in the prevalence of type 2 diabetes [1] as well as in the number
of mobile phone users [18]. According to the statistics provided
by the Telecom Regulatory Authority of India, the number of
wireless telephone users in India increased from around 1034
million in April 2016 to around 1174 million in January 2017,
that is, 100 million users added within a year [19]. Moreover,
the Internet and Mobile Association of India (IAMAI) and
Indian Market Research Bureau (IMRB) statistics have also
shown that India has the second largest population using the
Internet, of which a large number gain access to the Internet
using their smartphones. The IAMAI and IMRB prediction for
the mobile-based Internet users is that there would be 371
million users by June 2017 from 306 million in December 2016,
which represents an increase of 21% in just 6 months [20]. This
massive upswing and uptake of technology in the field of mobile
technology renders mHealth as a liable opportunity to provide
individual-level support beyond traditional clinic-based care
technology [17,20-24].
With this background information, we took up a trial of primary
prevention of diabetes based on mHealth. The aims of this trial
are to understand the feasibility, cost-effectiveness, and
sustainability of a reality television–based lifestyle intervention
delivered via a mobile phone app along with the support of a
health coach for 12 weeks and to evaluate its effect on weight
loss, cardiometabolic risk factors, and behavioral and social
variables, such as physical activity, quality of life (QOL), and
adoption of healthier diet and lifestyle behaviors, in Android
mobile phone users who are at a high risk of developing T2DM.
Methods
Study Design and Participants
This study is an RCT being conducted at three cities in India
(Chennai, Bengaluru, and New Delhi) between 2016 and 2018.
Android mobile phone users, between the age groups of 20 and
65 years, are screened for eligibility based on a combination of
screening criteria detailed in Figure 1. The rationale for choosing
Android users is based on the data published in 2016 that 97%
of the mobile phone users in India use the Android operating
system [25]. This figure rose from 90% in 2015 [25].
Eligibility Criteria
The screening criteria are designed to ensure that individuals at
a high risk of developing diabetes are selected for the study. To
select the high-risk group, a combination of the Indian Diabetes
Risk Score (IDRS), body mass index (BMI), and capillary blood
glucose (CBG) is used.
Figure 1. Eligibility criteria at screening and baseline. IDRS: Indian Diabetes Risk Score; BMI: body mass index.
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IDRS is a simplified and validated tool that uses 4 parameters,
namely, age, abdominal obesity, family history of diabetes, and
physical activity [26,27]. It was shown that a high IDRS score
increases with the risk of T2DM, metabolic syndrome, and
cardiovascular disease [28]. Generally, an IDRS score of 40
indicates a moderate risk of developing diabetes and a score of
60 indicates a high risk. For the purpose of including a wide
range of high-risk population, we classified an IDRS score of
≥40, along with either a BMI indicative of obesity or CBG
indicative of prediabetes (IFG=100-125 mg/dL or IGT=110-199
mg/dL) to determine eligibility at screening. However, an IDRS
score of ≥60 is considered as an independent criterion to
determine eligibility. BMI is an important diagnostic marker
for overweight and obesity [29]. We set a cut point of ≥23
kg/m2to indicate overweight and obesity as defined by the WHO
Asia Pacific guidelines [30], and this is used in combination
with CBG, indicating prediabetes and/or and an IDRS ≥40.
However, a BMI ≥25 kg/m2 is considered as an independent
criterion to determine eligibility. The CBG testing is used to
identify an IFG of 100 to 125 mg/dL or an IGT of 110 to 199
mg/dL at screening using the WHO cut-offs [31]. The final
eligibility criterion for entry into the trial is defined as either an
IFG of 100 to 125 mg/dL and/or an IGT of 140 to 199 mg/dL
through a 75-g oral glucose tolerance test and/or a BMI ≥25
kg/m2, indicating obesity at baseline (Figure 1).
The exclusion criteria for the study are participants who are
pregnant or breastfeeding, are involved in other wellness
programs, whether they have been previously diagnosed with
diabetes or have a history or evidence of heart disease or any
other serious illness, are children or young people (ie, aged <20
years) or older adults (ie, aged >65 years), or have conditions
(such as orthopedic conditions) that would impede participation
in this study.
Recruitment
Recruitment is carried out through screening camps at clinic
settings, corporates/worksites, residential colonies/gated housing
complexes, educational institutions, religious or spiritual
institutes, open public spaces, and direct referrals (such as
participants referred by study staff and physicians) to cover the
general population at large.
If an individual fulfilled 1 or more of the criteria enlisted in
Step 1 (Figure 1), they are invited for baseline testing, and each
participant is subjected to a panel of tests as detailed in Table
1 to ensure final eligibility into the study (Step 2 in Figure 1).
At each site, approximately 3000 people are screened based on
the screening criteria shown in Figure 1, and approximately
1000 individuals would be available for baseline testing. The
main aim of the baseline visit is to ensure that the individuals
screened do not have type 2 diabetes [31] or fall under any other
exclusion criteria and that they have understood the requirements
of the intervention study. A summary of measures that are
conducted at each visit are detailed in Table 1 and Multimedia
Appendix 1.
Table 1. Summary of study measures.
End of follow-upPost interventionBaselineScreeningMeasurements
Questionnaires
✓Short questionnaire
✓✓✓Questionnaires measuring participants’ health habits, diet
behavior, quality of life, health-related costs, and physical
activity/inactivity
Anthropometry
✓✓✓Weight (in kg)
✓✓✓Height (in cm)
✓✓✓✓Waist circumference (in cm)
✓✓✓Body fat (%)
✓✓✓Blood pressure
✓Indian Diabetes Risk Score
Biochemical parameters
✓Capillary blood glucose
✓✓✓Venous fasting blood glucose
✓✓Postglucose load (2 hours)
✓✓✓Fasting insulin assay
✓✓✓HbA1c
✓✓✓Lipid profile
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Randomization
A study staff not involved in the study randomizes the
participants into the intervention and control group across sites
by the random allocation sequence method using a random
numbers table. The randomization grid, which contained only
the study unique ID number and inclusion criteria variables, is
filled at each site by the site coordinators and sent to the
personnel at the central randomization site as per the weekly
randomization schedule. The grids are sent back to the sites post
randomization. Therefore, the study personnel randomizing the
participants are blinded to the group allocation of the
participants, whereas the study team and participants at each
site are not.
Control Group
The control group participants receive usual care for patients
with prediabetes or obesity at all the 3 study sites. They meet a
nutritionist once after randomization and receive handouts
reinforcing prevention of T2DM through increased physical
activity and weight loss. All control group participants are
offered access to the app at the end of the study.
The Mobile App Description
An mHealth app called mDiab is used by all intervention group
participants. mDiab has 12 weeks of video lessons that were
created based on the Diabetes Community Lifestyle
Improvement Program (D-CLIP) lessons and experiences [16],
which in turn were originally developed using the US Diabetes
Prevention Program. The video lessons are in the form of a
reality television show, where real actors role-play and enact
the concepts of lifestyle behavior change. This inspires and
motivates the participants viewing the video lessons in the app
to change their lifestyles to improve their health. For example,
for the video lesson on incorporating a healthy diet, the actors
act out ways to help the participant understand the concept and
share experiences on the challenges faced while adopting it in
real life. They also help in overcoming the challenges by
suggesting suitable solutions. Apart from the video lessons, the
app also has goal setting, alerts, and small text modules, which
are brief write-ups on the video lessons. There are also
multiple-choice questions to help reinforce learning. The 12
weeks of video lessons cover various aspects of T2DM
prevention, with the goal of reducing diabetes risk through
weight loss of at least 5%. The contents of the video lessons are
described in Table 2 and Multimedia Appendix 2. Overall, the
app has 3 important components—the video lessons as described
above, tracking of behaviors, and weekly calls by the health
coaches.
Tracking
This feature of the app is meant to enable users to track their
diet, physical activity, and weight. The calorie and fat goals
provided are based on the D-CLIP study. The participants are
encouraged to track their daily food intake. The food database
is developed using the Dr Mohan’s Diabetes Food Atlas [32]
and National Institute of Nutrition’s guidelines [33]. The activity
tracker automatically counts the number of steps using the
mobile phone’s inbuilt accelerometer sensor. Additionally, the
participant is encouraged to add any specific activity he/she
likes to do. The weight tracker sets an initial weight loss goal
of 5% and enables tracking. Every participant in the intervention
group receives a weighing scale as an incentive to enable them
to track their weight. The app sends out standardized reminders
and motivational messages according to the progress of each
user. Screenshots of the app’s tracking features are shown in
Figure 2 for better understanding.
Communication With the Health Coach
Health coaches in the mDiab program are trained nutritionists
who call participants once a week to inform them about the
objectives of the video lessons and their progress and finally
email them with a progress report using the data tracked by the
respective participant. The participants also have the opportunity
to communicate with the health coaches in any case via a
message tool inbuilt in the app, and the health coaches respond
to the participants in 24 hours.
Procedures
Data Collection
At screening, the participant’s basic demographic details, IDRS,
and CBG are measured. Post that, the study has a total of 3
testing time points including baseline, post intervention, and
end of follow-up. All testing visits (except screening) occur
after an overnight fast of at least 8 to 10 hours. The study
participants are administered a questionnaire to record their
sociodemographic data at baseline. Changes in diet and
frequency of consumption of common foods are assessed using
a 3-day diet recall, and short validated food frequency
questionnaires are administered at all visits. Mobile phone usage
and mHealth efficacy are also assessed at all visits. Physical
activity and exercise behaviors are recorded using the short
Madras Diabetes Research Foundation Physical Activity
Questionnaire (MPAQ). MPAQ is a reproducible and validated
instrument that captures data from multiple activity domains
(including sedentary activity) over a period of a year from adults
of both genders and varying ages from various walks of life,
residing in India [34]. The participant’s QOL is assessed using
the WHOQOL-BREF instrument comprising 26 items [35]. It
measures 4 broad domains: physical health, psychological
health, social relationships, and environment. We also aim to
assess the cost-effectiveness of using the mHealth intervention
by assessing the incremental costs and benefits per
quality-adjusted life-year (QALY). The cost-effectiveness of
the mHealth intervention from an individual and collective
perspective is compared with usual care by conducting
incremental cost-effective analyses in which the net costs and
net effectiveness of the mHealth intervention and the usual care
are calculated and expressed as a ratio. All analyses are within
the time frame of the trial. The direct medical and nonmedical
costs/indirect costs associated with the mHealth intervention
over 10 to 12 months are included in the cost-effectiveness [36].
Program adherence is measured by monitoring how well the
participants used the various features of the app by responding
to reminders and alerts. This is tracked using a Web-based
dashboard. A 75-g glucose tolerance test [37] at 0 and 120 min
along with blood tests for insulin, glycated hemoglobin (HbA1c),
and lipids are conducted at baseline and at the annual follow-up
visit.
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Table 2. mDiab overview of video lessons.
ObjectivesSessions (Weekly)
Effective and daily tracking using the habits programSession 1: Importance of self-monitoring
The importance of breakfast as a wholesome and balanced meal, along with sample meal
plans
How one can be in charge of their health beyond all daily challenges, including overloaded
work schedule, trials of family life, involved social life, and healthy lifestyle changes
Plan one’s day by planning the right time for eating
Being true to oneself and achieving success
Sleeping well for a healthy lifestyle
Staying on track during the weekend
Rewarding oneself
Learning how fat and calories can affect healthSession 2: Fat and calorie detective
Learning where to find them in food
Importance of portion sizes and measurement of food
Being aware of fattening foods and hidden fats and switching to low-fat options to improve
health and alleviate the risks of heart disease and diabetes
Practicing being more aware and choosing food items consciously with lesser calories
and fats, dwelling more into measuring foods
Understanding that correlating the quantity of food eaten to its nutrient contribution
(calories and fats) helps to remain within the fat and calorie limit for the day that is pre-
determined by one’s initial weight
Using one’s skills to ration portions and choose food items judiciously by evaluating the
consolidated caloric intake for the day; trying to find a balance through food and exercise
Incorporating physical activity into your lifestyle
Understanding the importance of taking a balanced meal and learning what it looks likeSession 3: Having a balanced meal
Getting the relevance of the “My plate” concept
Understanding what it is to eat from different food groups
Learning the good side of everything, especially fats
Understand the balance between calories in and calories out by tipping the calorie balance
and understanding the food serving sizes
Techniques to make physical activity funSession 4: Being active
The FITT principle to balance your activity
Exercises—leg raises and back extensions
Reviewing what was learnt and putting it to practice
Understanding the serious threat of sedentary lifestyle and keeping a track of F—frequency,
I—intensity, T—type of activity, and T—time
Keeping food and activity cues by simplifying them to one’s core problemsSession 5: Learning about ourselves
Learning how our environment causes us to be unhealthy
Becoming aware of temptations that might steer one off course
Steps to problem-solving
Singling out areas in need of improvement and creating an action plan focusing on making
these changes gradually
Use tracking to one’s advantage
The healthy side of eating outSession 6: Strategies for eating out
Learning how to control what you eat when not at home
Ordering healthy
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ObjectivesSessions (Weekly)
Planning ahead when going out to eat with friends or family
Managing and dealing with slip-upsSession 7: Managing slip-ups
Identifying the reasons for a slip-up
Identifying negative thoughts and learning how to manage them
Stretching exercises and learning some seated stretching techniques
Understanding common external triggers for mismanaging diet and exercise and dealing
with them
Understanding social cues and how they affect usSession 8: Understanding social cues
Making lifestyle changes using social cues to one’s advantage
Being aware of your social interactions and how they affect you
Learning to positively affect outcomes of unhealthy social cues
Improving strength and flexibilitySession 9: Improving strength and flexibility
Strengthening one’s exercise program and learning resistance training
Standing up for your health
Incorporating strength training into your activity routine
Understanding the importance and concept of volumetrics and eating mindfullySession 10: Volumetrics and eating mindfully
High volume, low calorie foods—learning to eat more food that has fewer calories
Eating mindfully by perceiving your physical and mental state
Thinking before eating and being aware how one eats
Paying attention to size, smell, texture, taste, and its other qualities
Enjoying one’s meal to its fullest
Maintaining the momentumSession 11: Stress management and staying motivated
Recognizing positive lifestyle changes made so far
Stress management
Combating stress with planned activity or a healthy session of yoga
Nurturing your heart into a healthy heartSession 12: Long-term heart health
Understanding the importance of reducing risk of heart diseases by adopting positive
lifestyle changes
Understanding the importance of the new habits you have developed
Using your skills to successfully keep the new habits you have created
Keeping a schedule—tracking your new skill
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Figure 2. mDiab app screenshots.
At the post-intervention visit (3rd-month visit), fasting glucose,
insulin, HbA1c, and lipids are measured. Height is measured at
baseline visit, and anthropometry (height, weight, waist
circumference, and body fat) and clinical measures (blood
pressure) are measured at baseline, post intervention, and end
of follow-up visits.
Program Acceptability
Program acceptability is assessed through focus group
discussions (FGDs) with the intervention group participants at
the end of follow-up. We plan to organize 2 FGDs at each site
consisting of at least eight participants each. Thus, a total of 6
FGDs will be conducted in the study. The participants will be
encouraged to share their experience on the benefits and
problems of the intervention, financial worth of the program,
and suggestions, if any, for improvement. Participants who drop
out will also be contacted to understand their reasons for
dropping out and to obtain their feedback.
Sample Size Calculation
Our study randomizes 1500 individuals across 3 sites to receive
either the mHealth diabetes prevention program or usual care
with a 6-month maintenance period. Considering an obesity
prevalence of 20% as reported in the Indian Council of Medical
Research-India Diabetes (ICMR-INDIAB) study [38,39] and
with south Asians having a low BMI threshold compared with
the rest of the population, 5% weight loss was determined as
the primary outcome in the intervention group. On the basis of
this assumption, a sample size of 588 individuals in each arm
will be required to obtain a minimum of 3% difference in weight
loss between groups with a power of 80% and a significance
level of 5%. As this is a mobile phone–based intervention study,
expecting a slightly higher dropout rate of 25%, 735 individuals
in each group will need to be tested in the trial, resulting in a
total of 1470, which has been rounded off to a total of 1500
individuals across 3 sites (500 per site).
All sample size and power calculations were done using the
OpenEpi (The OpenEpi Project, Version 3, Atlanta, Georgia).
Ethics Approval
The study protocol was approved by the Institutional Ethics
Committee at Madras Diabetes Research Foundation, All India
Institute of Medical Sciences, and the Human Research Ethics
Committee at Deakin University, Australia. Consent is obtained
from all participants. At baseline testing, all participants were
also given a plain language statement of the study.
Statistical Analysis
Quantitative analyses of the obtained data will be conducted in
STATA (StataCorp, Version 15, College Station, Texas) and
SPSS (IBM SPSS Statistics for Windows, Version 24.0.
Armonk, NY). A probability of <0.05 will be considered
statistically significant for all tests. Effectiveness of the
intervention will be assessed by measuring the differences in
the study arms in terms of the primary outcome, weight loss
and secondary outcomes, behavioral and social variables, and
cost-effectiveness. Continuous variables will be assessed for
normality, and anomalous values will be categorized. All
variables will undergo descriptive analyses. t tests will be used
to compare between the 2 groups. Data will be presented before
and after adjusting for confounders. Qualitative data include
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analyses of the audiotaped transcripts from the FGDs. The
transcripts will be de-identified, and textual data will be
extracted from the same. Following this, key themes will be
identified and reported.
Cost-Effectiveness
Two sets of outcomes are used to measure cost-effectiveness:
cost-effectiveness analysis, which is the incremental cost per
case of diabetes prevented, and cost-utility analysis, which is
the incremental cost per QALY. The cost-effectiveness of the
mHealth intervention is represented by the ratio of incremental
cost to increment effectiveness. In addition, sensitivity analyses
will be performed to examine effects of key parameters on
cost-effectiveness ratios [36].
Discussion
Mobile phone technology has been shown to have wide
acceptance across various age groups and socioeconomic groups.
It offers several opportunities for self-management as well as
prevention of T2DM [40-42]. The mDiab study looks at the
effect of combining various mHealth technologies that could
all act as an effective tool for diabetes prevention in high-risk
Asian Indians. The intervention is unique in that it is backed by
evidence provided by the D-CLIP study [43]. The D-CLIP study
was an RCT that compared an intervention group, which
received 16 weekly sessions on lifestyle behavior change,
nutrition, and physical activity, followed by 8 weeks of
maintenance classes, with a control group that received standard
of care. Individuals in the intervention arm who remained at
high risk, that is, those with an HbA1c of >5.6% after 4 or more
months in the program, received metformin, in addition to the
lifestyle program. The goals for the individuals were set as
weight loss of at least 7% and 150 min or more of moderate
physical activity. In the mDiab intervention, however, we
lowered the weight loss goal based on the learnings from the
D-CLIP study as most Indians are not overtly obese. The
D-CLIP results showed an almost 50% risk reduction in the
obese population, and the numbers needed to treat were 6.8,
which means that if 7 “high-risk cases” are given the
intervention, one case of diabetes can be prevented [43].
On the basis of the D-CLIP results, the need to scale up diabetes
prevention in India was felt, and mobile technology was thought
of as a tool to introduce the intervention. This was the basis for
the mDiab trial. Very few studies have been carried out in India
to test the efficacy of mHealth technology in diabetes prevention.
Ramachandran et al [44] studied the effect of SMS text
messaging (short message service, SMS) in a high-risk
population and showed that it is possible to decrease the
incidence of diabetes with almost 10% difference between the
groups by using a structured SMS text messaging intervention.
However, their population sample was limited to working Indian
men only. In another study that evaluated the impact of mobile
SMS text messages on self-reported diabetes awareness and
prevention behaviors among cell phone users in India, it was
observed that the intervention group showed 15% improvement
in their dietary and physical activity behaviors compared with
the control group [45].
Globally, many studies have shown significant improvements
in glycemic control using mobile phone technology. Hussein
et al [46] showed that continuous and individualized support
and interaction with a diabetes educator and a clinician through
SMS text messages could decrease the HbA1c by 1.16% in
individuals with type 2 diabetes. Studies using SMS technology,
based on knowledge, attitude, practice, and self-efficacy and
motivation, have shown improvement in glycemic control
[47,48]. Some studies have also looked at secondary prevention
of diabetes by enforcing self-management of lifestyle behavior,
insulin therapy, medications, and physician visits [49,50]. The
study by Browne et al [51] reported that younger adults are
more susceptible to using eHealth services for diabetes
self-management. This may be because younger adults were
tech-savvy and found using eHealth self-management supports
time-saving. The Diabetes MILES (Management and Impact
for Long-term Empowerment and Success)—Australia study
[52] reported that telehealth and eHealth are promising areas
for diabetes management, especially to reach out to wider
population groups.
In the context of rapid adoption of mobile technology [18] and
the fast rise of the T2DM epidemic in LMICs such as India
[1-3], mDiab is an RCT testing the effectiveness,
cost-effectiveness, and sustainability of a culturally tailored
mHealth diabetes prevention program for Asian Indians. If
successful, mDiab can be used as a model for translational and
implementation research on the use of mHealth technology for
diabetes prevention. Indeed, the mDiab experience can be further
expanded to the prevention of other noncommunicable diseases
such as hypertension and cardiovascular diseases.
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